Monash IVF Group Limited (ASX:MVF)
Australia · Delayed Price · Currency is AUD 0.7250
+0.0150 (2.11%)
Oct 28, 2026, 4:10 PM AEDT
Monash IVF Group Market Cap
Monash IVF Group has a market cap or net worth of 282.49 million as of October 27, 2026. It is the 20,752nd most valuable company in the world and the 403rd biggest in Australia. Its market cap has increased by 2.84% in one year.
Market Cap
282.49M
Enterprise Value
477.57M
Revenue
269.46M
Global Rank
Country Rank
#403 Australia
PE Ratio
38.16
ChartMarket Cap Chart
Since June 26, 2014, Monash IVF Group's market cap has decreased from 534.53M to 282.49M, a decrease of -47.15%. That is a compound annual growth rate of -5.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 282.49M | -1.36% |
| Dec 31, 2025 | 286.38M | -42.13% |
| Dec 31, 2024 | 494.84M | -2.31% |
| Dec 29, 2023 | 506.53M | 36.13% |
| Dec 30, 2022 | 372.10M | -9.48% |
| Dec 31, 2021 | 411.06M | 34.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 793.40M |
| Australian Clinical Labs | 547.74M |
| Healius | 330.40M |
| Identifai Genetics | 64.31M |
| Cryosite | 59.55M |
| BCAL Diagnostics | 29.49M |
| Microba Life Sciences | 24.51M |
| Rhythm Biosciences | 23.00M |